Literature DB >> 10567278

Predictors of the long-term outcome after combined aortic and mitral valve surgery.

J Turina1, T Stark, B Seifert, M Turina.   

Abstract

BACKGROUND: The influence of preoperative clinical, hemodynamic, and surgical procedures on long-term prognosis after combined aortic and mitral valve surgery is not well known. METHODS AND
RESULTS: One hundred seventy patients (mean age, 50.5 years; 102 men and 68 women) who underwent surgery for chronic combined aortic and mitral valvular disease between 1975 and 1989 were followed up for an average of 10.6 years. Additional repair of tricuspid valve was performed in 29 patients (17%), and aortocoronary bypass graft surgery was performed in 7 patients (4.1%). The perioperative mortality rate was 4%, and 10- and 20-year survival rates were 61% and 33%. Only 12 of 94 deaths (11%) were non-cardiac related. At 10 and 20 years, 57% and 21% of patients were free of reoperation, respectively. The main predictors of late survival in univariate analysis were age at surgery (P=0.0002), preoperative left ventricular ejection fraction (P=0.002), cardiac index (P=0.007), tricuspid surgery (P=0.03), pulmonary vascular resistance (P=0.03), NYHA class (P=0.04), and additional aortocoronary bypass graft surgery (P=0.04). Duration of symptoms, gender, cause of valvular disease, and type of prosthesis were not predictive of postoperative outcome. In multivariate stepwise Cox analysis, ejection fraction (P=0.0008), age at surgery (P=0.0011), and tricuspid surgery (P=0. 007) were independent predictors of late survival.
CONCLUSIONS: In combined aortic and mitral valve disease, preoperative myocardial function is the main predictor of long-term survival. Low operative mortality rates and good late outcome make valve replacement mandatory before deterioration of myocardial function occurs. Additional tricuspid valve disease requiring surgery significantly decreases the late survival rate.

Entities:  

Mesh:

Year:  1999        PMID: 10567278     DOI: 10.1161/01.cir.100.suppl_2.ii-48

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Choice of prosthetic heart valve in a developing country.

Authors:  Shiv Kumar Choudhary; Sachin Talwar; Balram Airan
Journal:  Heart Asia       Date:  2016-04-28

2.  Prognostic implications of tricuspid regurgitation in patients with severe aortic regurgitation: results from a cohort of 756 patients.

Authors:  Padmini Varadarajan; Ramdas G Pai
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-17

3.  Prognostic value of exercise left ventricular end-systolic volume index in patients with asymptomatic aortic regurgitation: an exercise echocardiography study.

Authors:  Yukio Sato; Masaki Izumo; Kengo Suzuki; Seisyou Kou; Kihei Yoneyama; Maya Tsukahara; Kanako Teramoto; Keisuke Minami; Shingo Kuwata; Ryo Kamijima; Kei Mizukoshi; Akio Hayashi; Sachihiko Nobuoka; Eiji Ohtaki; Tomoo Harada; Yoshihiro J Akashi
Journal:  J Echocardiogr       Date:  2016-11-21

4.  Transatrial intrapericardial tricuspid annuloplasty.

Authors:  Toby Rogers; Kanishka Ratnayaka; Merdim Sonmez; Dominique N Franson; William H Schenke; Jonathan R Mazal; Ozgur Kocaturk; Marcus Y Chen; Anthony Z Faranesh; Robert J Lederman
Journal:  JACC Cardiovasc Interv       Date:  2015-02-18       Impact factor: 11.195

5.  Mitral valve repair versus replacement in simultaneous aortic and mitral valve surgery.

Authors:  Marian Urban; Jan Pirk; Ondrej Szarszoi; Ivo Skalsky; Jiri Maly; Ivan Netuka
Journal:  Exp Clin Cardiol       Date:  2013

6.  Computational investigation of left ventricular hemodynamics following bioprosthetic aortic and mitral valve replacement.

Authors:  Fei Xu; Emily L Johnson; Chenglong Wang; Arian Jafari; Cheng-Hau Yang; Michael S Sacks; Adarsh Krishnamurthy; Ming-Chen Hsu
Journal:  Mech Res Commun       Date:  2020-10-16       Impact factor: 2.254

7.  Comparison of goal-directed hemodynamic optimization using pulmonary artery catheter and transpulmonary thermodilution in combined valve repair: a randomized clinical trial.

Authors:  Andrey I Lenkin; Mikhail Y Kirov; Vsevolod V Kuzkov; Konstantin V Paromov; Alexey A Smetkin; Mons Lie; Lars J Bjertnæs
Journal:  Crit Care Res Pract       Date:  2012-04-30

8.  Implantation of mitral, aortic, and tricuspid bioprostheses due to infective endocarditis with necessary reimplantation of the bioprosthetic aortic valve.

Authors:  Cezary Danielecki; Paweł Bugajski; Roman Olszewski; Krzysztof Greberski; Ryszard Kalawski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-09-30

9.  Initial Experience of Minimally Invasive Concomitant Aortic and Mitral Valve Replacement/Repair at a Tertiary Care Cardiac Centre of a Developing Country.

Authors:  Kashif Zia; Ali R Mangi; Hafeezullah Bughio; Khuzaima Tariq; Pervaiz A Chaudry; Musa Karim
Journal:  Cureus       Date:  2019-09-20

10.  Risk Prediction in Aortic Valve Replacement: Incremental Value of the Preoperative Echocardiogram.

Authors:  Timothy C Tan; Aidan W Flynn; Annabel Chen-Tournoux; Lawrence G Rudski; Praveen Mehrotra; Maria C Nunes; Luis M Rincon; David M Shahian; Michael H Picard; Jonathan Afilalo
Journal:  J Am Heart Assoc       Date:  2015-10-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.